330 related articles for article (PubMed ID: 28359690)
1. Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer.
Scott SA; van der Zanden C; Cai E; McGahan CE; Kwon JS
Gynecol Oncol; 2017 May; 145(2):262-268. PubMed ID: 28359690
[TBL] [Abstract][Full Text] [Related]
2. [Clinical implications of positive peritoneal cytology in endometrial cancer].
Ren YL; Wang HY; Shan BE; Ping B; Shi DR
Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance and treatment implications of positive peritoneal cytology in endometrial adenocarcinoma: Unraveling a mystery.
Wethington SL; Barrena Medel NI; Wright JD; Herzog TJ
Gynecol Oncol; 2009 Oct; 115(1):18-25. PubMed ID: 19632708
[TBL] [Abstract][Full Text] [Related]
4. Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer.
Matsuo K; Matsuzaki S; Nusbaum DJ; Machida H; Nagase Y; Grubbs BH; Roman LD; Wright JD; Harter P; Klar M
Eur J Cancer; 2020 Jul; 133():33-46. PubMed ID: 32434109
[TBL] [Abstract][Full Text] [Related]
5. Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer Database.
Seagle BL; Alexander AL; Lantsman T; Shahabi S
Am J Obstet Gynecol; 2018 Mar; 218(3):329.e1-329.e15. PubMed ID: 29223598
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT
Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898
[TBL] [Abstract][Full Text] [Related]
7. High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy.
Sonoda Y; Zerbe M; Smith A; Lin O; Barakat RR; Hoskins WJ
Gynecol Oncol; 2001 Mar; 80(3):378-82. PubMed ID: 11263935
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal cytology: a risk factor of recurrence for non-endometrioid endometrial cancer.
Han KH; Park NH; Kim HS; Chung HH; Kim JW; Song YS
Gynecol Oncol; 2014 Aug; 134(2):293-6. PubMed ID: 24854062
[TBL] [Abstract][Full Text] [Related]
9. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
Ivanov I
Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
[TBL] [Abstract][Full Text] [Related]
10. Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification.
Werner HM; Trovik J; Marcickiewicz J; Tingulstad S; Staff AC; Amant F; Salvesen HB;
Gynecol Oncol; 2012 Apr; 125(1):103-8. PubMed ID: 22100838
[TBL] [Abstract][Full Text] [Related]
11. The significance of peritoneal cytology in uterine cervix and endometrial cancer.
Kashimura M; Sugihara K; Toki N; Matsuura Y; Kawagoe T; Kamura T; Kaku T; Tsuruchi N; Nakashima H; Sakai H
Gynecol Oncol; 1997 Dec; 67(3):285-90. PubMed ID: 9441776
[TBL] [Abstract][Full Text] [Related]
12. Patterns of practice and outcomes in intermediate- and high-risk stage I and II endometrial cancer: a population-based study.
Kwon JS; Carey MS; Cook EF; Qiu F; Paszat L
Int J Gynecol Cancer; 2007; 17(2):433-40. PubMed ID: 17309565
[TBL] [Abstract][Full Text] [Related]
13. Tumour-free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancer.
Chattopadhyay S; Galaal KA; Patel A; Fisher A; Nayar A; Cross P; Naik R
BJOG; 2012 Sep; 119(10):1162-70. PubMed ID: 22804815
[TBL] [Abstract][Full Text] [Related]
14. Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer.
Matsuo K; Yabuno A; Hom MS; Shida M; Kakuda M; Adachi S; Mandelbaum RS; Ueda Y; Hasegawa K; Enomoto T; Mikami M; Roman LD
Gynecol Oncol; 2018 May; 149(2):301-309. PubMed ID: 29605499
[TBL] [Abstract][Full Text] [Related]
15. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
16. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
17. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
[TBL] [Abstract][Full Text] [Related]
18. Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer.
Akbayır O; Corbacıoglu Esmer A; Numanoglu C; Cılesız Goksedef BP; Akca A; Bakır LV; Kuru O
Arch Gynecol Obstet; 2012 Nov; 286(5):1269-76. PubMed ID: 22729137
[TBL] [Abstract][Full Text] [Related]
19. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
20. The prognostic role of peritoneal cytology in stage IA endometrial endometrioid carcinomas.
Wang L; Li L; Wu M; Lang J
Curr Probl Cancer; 2020 Apr; 44(2):100514. PubMed ID: 31753315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
